The mechanism by which peripheral membrane proteins are targeted to the cytoplasmic face of the Golgi apparatus is poorly understood. Previously, we have identified a carboxy-terminal domain of the trans-Golginetwork (TGN) protein p230 that is responsible for Golgi localisation [1]. Here, we report the identification of a similar Golgi-localisation domain (GLD, also termed the 'GRIP' domain -see the paper by Munro and Nichols elsewhere in this issue) in a family of putative peripheral membrane proteins from lower and higher eucaryotes. The majority of family members have a domain structure similar to that of p230, with extensive coiled-coil regions (>80%) and the potential GLD located in a non-coiledcoil domain at the carboxyl terminus. Previously reported proteins in this family include human golgin-97 and Saccharomyces cerevisiae Imh1p. By constructing chimeric cDNAs encoding carboxy-terminal regions of these family members fused to green fluorescent protein (GFP), we have directly demonstrated that the GLD of p230, golgin-97, the newly identified human protein GCC1p and yeast Imh1p functions as a Golgitargeting domain in transfected mammalian cells. Sitedirected mutagenesis of the GLDs identified two conserved aromatic residues that are critical for the function of this targeting domain. Endogenous p230 was displaced from the Golgi membranes in transfected cells expressing high levels of GFP fused to the GLD of either p230 or golgin-97, indicating that different GLDs interact with similar membrane determinants. Thus, we have identified a family of coiled-coil proteins that share a domain shown to be sufficient for the localisation of peripheral membrane proteins to the Golgi apparatus.
Results and discussion
The peripheral membrane protein p230 contains extensive coiled-coil regions, and is localised to the cytoplasmic side of TGN membranes as well as to non-clathrin-coated vesicles budding from the TGN [2] [3] [4] . We have shown that the non-coiled-coil carboxy-terminal domain of p230 is responsible for Golgi localisation [1] . Within the 98 amino-acid carboxy-terminal domain of p230, a minimum stretch of 42 residues was identified that displayed a Golgi-targeting sequence; however, the amino acids flanking this 'minimal targeting sequence' greatly increased the efficiency of Golgi targeting [1] , possibly as a result of increased accessibility and/or proper folding of the targeting sequence. The sequence of the 98 amino-acid carboxy-terminal domain of p230 was used in a search of sequences in a variety of databases. Eight full-length sequences were identified that showed significant relationship to the p230 GLD. Strikingly, seven of these proteins are predicted to contain very extensive (>80%) coiled-coil domains, similar to p230 ( Figure 1b ). All the GLDs were located in a carboxy-terminal position, as for the p230 GLD, supporting the possibility that they have a similar function. The alignment of the relevant sequences of these proteins is shown in Figure 1a . Notably, the similarity in sequence was observed only within the 42 amino-acid minimal targeting sequence of p230 ( Figure 1a ). No sequence similarity was observed in the sequences flanking this 42-residue stretch.
Sequences identified with coiled-coil domains include three additional human proteins, one from S. cerevisiae, and three from Caenorhabditis elegans. The human sequences include the peripheral Golgi-membrane protein golgin-97 [5] and two putative proteins, GCC1p and KIAA0336. These three proteins have approximately 60% sequence similarity to p230 within the 42 amino-acid core of the GLD. One of the proteins is derived from the DNA cosmid sequence, g1572c101 (Genbank accession number AC000357), and is predicted to encode a protein of 633 amino acids (referred to as GCC1p for Golgilocalised coiled-coil protein). The other human protein, KIAA0336 (Genbank accession number AB002334), is predicted to encode a protein of 1583 amino acids. The lack of putative transmembrane domains in GCC1p and KIAA0336 is consistent with them being peripheral membrane proteins. S. cerevisiae Imh1p, a predicted protein of 912 amino acids with extensive coiled-coil domains, also contains a potential GLD at its carboxyl terminus. Imh1p was identified as a suppressor of a temperature-sensitive yeast strain that lacks the functional small GTPase Rab6 homologue, Ypt6p [6] . The phenotype of the YPT6 defective strain includes defects in carboxypeptidase Y maturation. The ability of Imh1p to suppress these defects suggests that it can influence the secretory pathway, perhaps through Rab6. Finally, three predicted openreading frames from C. elegans that were identified within the GLD family (CE00321, CE03434, CE03988) also have extensive coiled-coil domains (Figure 1b ). Another sequence that had a GLD was also identified but this protein lack coiled-coil domains. Ran-binding protein 2α (RanBP2α), a recently described protein encoded by a member of the RanBP2 gene cluster [7] , has a GLD at the carboxyl terminus which is absent in RanBP2. Interestingly, the GLD sequence of RanBP2α is almost identical to the GLD of KIAA0336, suggesting a gene duplication event. Because RanBP2α does not have regions of coiledcoil structure, it appears that GLDs are not restricted to proteins containing extensive coiled-coil domains.
To test whether the domains homologous to the p230 can GLD act as Golgi-targeting sequences, we made chimeric cDNAs encoding the non-coiled-coil carboxy-terminal domains of golgin-97 (87 amino acids), human GCC1p (70 amino acids) or Imh1p (86 amino acids) fused to the carboxyl terminus of GFP. COS cells were transfected with these constructs and with GFP-p230-GLD for comparison. Significantly, the resulting fusion proteins were all localised to the Golgi (Figure 2) , as indicated by the concentrated juxtanuclear fluorescence; the three human-derived sequences, GFP-p230-GLD, GFP-golgin-97-GLD and GFP-GCC1p-GLD, were all efficiently localised to the Golgi region of transfected COS cells (Figure 2a-c) . The yeast-derived sequence, GFP-Imh1p-GLD, was also localised to the Golgi region, albeit less efficiently than the other constructs (Figure 2d,e) , indicating that the GLDs are functionally conserved between yeast and mammalian cells. In contrast, wild-type GFP was distributed in the cytoplasm and nucleus of transfected COS cells (Figure 2f) , consistent with previous findings [8] . Endogenous p230 was detected in the GFP-expressing cells with an affinity-purified human anti-p230 antibody that recognises epitopes outside the carboxy-terminal domain. Staining of transfected COS cells expressing low levels of the GFP fusion protein with the human anti-p230 antibodies revealed that, in each case, the GFP fusion protein co-localised with endogenous p230, confirming the Golgi location of the GFP fusion proteins (data not shown).
Sequence comparisons revealed that the only region that is well conserved throughout all members of the family of coiled-coil proteins lies near the amino terminus of the minimum targeting sequence of p230 ( Figure 1a ). In particular, a tyrosine at position 4 of the minimum targeting sequence is the only residue conserved throughout the entire family ( Figure 1a ). To determine whether this conserved tyrosine is required for the GLD to act as a targeting signal, this residue was replaced with alanine in .: : .. : GFP-p230-GLD by site-directed mutagenesis. When the mutated GFP-p230-GLD construct was expressed in COS cells, the resulting fusion protein was no longer targeted to the Golgi, but was localised throughout the cytoplasm (Figure 3b ). In contrast, substitution of the conserved tyrosine for phenylalanine did not significantly decrease the efficiency with which GFP-p230-GLD was localised to the Golgi (Figure 3c ), indicating a requirement for an aromatic residue at this position. The GFP fusion proteins were stable in transfected cells, as indicated by the presence of fluorescence in each case and by immunoblotting experiments, which demonstrated that the mutated GFP fusion proteins were the expected size and were present at similar levels as unmutated GFP-p230-GLD. Substitution of the conserved tyrosine residue for alanine in another GLD, namely that of GCC1p, also resulted in a complete loss of Golgi targeting of the relevant GFP fusion protein (data not shown), confirming the importance of this residue. Immunoprecipitation experiments demonstrated that GFP-p230-GLD was not phosphorylated (data not shown), a result consistent with the requirement for an aromatic residue, rather than tyrosine specifically, at this position.
In addition to the conserved tyrosine at position 4, a second conserved aromatic residue (tyrosine or phenylalanine) is also present at position 12 of the minimum targeting sequence (Figure 1a) . In p230, the aromatic residue at position 12 is tyrosine, and again substitution of this tyrosine for alanine in the GLD of p230 resulted in the loss of Golgi localisation of the GFP fusion protein (Figure 3d,e) . The abolition of Golgi targeting by single amino-acid substitutions supports the conclusion that these carboxyterminal domains contain a specific Golgi-targeting sequence. Furthermore, as the two critical aromatic residues are separated within the sequence, the result indicates that the targeting signal does not consist of a short discrete amino-acid sequence. The complex nature of the targeting signal is also demonstrated by the previous observation that Golgi localisation of the GFP-p230 fusion protein was abolished when blocks of six alanine substitutions were incorporated anywhere along the 42 amino-acid minimum targeting stretch [1] . Taken together, these results indicate the importance of two conserved aromatic residues, together with the overall conformation of the 42 amino-acid minimum targeting sequence, in conferring the ability of the GLD to act as a targeting domain.
Previously, we demonstrated that GFP-p230-GLD was able to displace endogenous p230 from Golgi membranes when present at high levels in transfected cells [1] . The question then arises as to whether the different family members are recruited to Golgi membranes through the same or different membrane structures that recruit p230. Therefore, we analysed the ability of the GLD of golgin-97 to compete with endogenous p230 for Golgi binding. In COS cells expressing high levels of GFP-golgin-97-GLD, the fusion protein was associated not only with the Golgi region but was also detected throughout the cytoplasm, indicating that Golgi binding was saturated ( Figure 4 ). In these cells expressing high levels of GFP-golgin-97-GLD, very little endogenous p230 was detected in the Golgi region, indicating that the GFP fusion protein was capable of displacing endogenous p230 from Golgi membranes, in a manner similar to that observed with GFP-p230-GLD ( Figure 4) . In contrast, endogenous p230 was not displaced from the Golgi in COS cells expressing high levels of mutated GFP-p230-GLD, with the tyrosine at position 4 substituted with alanine ( Figure 4) . Furthermore, in cells expressing high levels of GFP-golgin-97-GLD the localisation of the Golgi markers β-COP and γ-adaptin was similar to that of non-transfected cells, indicating that the Golgi structure was intact in these transfected cells (data not shown). This result demonstrates that the GLDs of golgin-97 and p230 may associate with the same Golgi target structure(s). Given that p230 is restricted to the membranes of the TGN [4] , these results suggest that golgin-97 is also localised to TGN membranes.
The localisation and behaviour of p230 suggests a role in vesicular transport [4] . Proteins with extensive coiled-coil domains, such as p115 and Uso1p, have been implicated in the docking or tethering of vesicles to target membranes [9] [10] [11] and it is possible that the family of molecules identified here may share a similar function. It is of interest that Imh1p was identified as a suppressor of a temperature-sensitive yeast mutant that lacks a functional Rab6 homologue [6] , and that deletion of both Imh1p (Sys3p) and yeast Rab6 greatly exacerbates the trafficking defect [12] . Significantly, Rab6 has been implicated in late Golgi transport in mammalian cells [13] , and it is now important to identify the nature of the structures that interact with the GLDs. The GLD has also been identified by Munro and Nichols and by F.A. Barr (this issue). Henceforth the domain shall be called the 'GRIP' domain.
Materials and methods

Analysis of databases for sequences related to the p230 GLD
Databases were searched for sequences related to the 98 amino-acid carboxy-terminal domain of p230 using the NCBI BLAST family of programs. C. elegans (Sanger Center) and S. cerevisiae (NCBI) protein sequences related to the p230 carboxy-terminal domain were identified by analysis of both protein and genomic databases. A partial sequence of the p230-related human protein, termed GCC1p, was initially identified within an EST cDNA clone, c-2ae12 (Genbank accession number Z46205). Searches for contiguous nucleic-acid sequences located the identical sequence within a human genomic cosmid g1572c101 (Genbank accession number AC000357). This genomic sequence was then analysed for putative genes using the Nucleotide Analysis Software maintained by the Computational Genomics Group at the Sanger Center. A 633 amino-acid open-reading frame was predicted. Coiled-coil predictions were performed using the COILS program [14] .
Predictions from the COILS program containing stretches of 21 or more amino acids with a probability greater than 0.5 were considered significant. ClustalX was used for multiple alignments of protein sequences [15] . The vector pEGFP-C1 (Clontech) was used for GFP constructs. Transfections of COS cells, immunofluorescene and immunoblotting were carried out as described [1, 4] .
Supplementary material
A background section and additional methodological detail is published with this paper on the internet. peripheral membrane proteins 
Background
Many resident Golgi proteins have been described that are specifically associated with the cytoplasmic face of Golgi membranes. These include matrix proteins, Golgilocalised cytoskeletal-associated proteins and proteins associated with the machinery of vesicular transport [S1]. Many of these peripheral membrane proteins recycle between the cytoplasm and Golgi membranes. In most cases, however, the basis for the specific membrane localisation has not been defined.
Using anti-Golgi autoantibodies from a patient with Sjö-gren's syndrome, we have previously identified a 230 kDa peripheral membrane protein, p230, specifically associated with vesicles budding from the TGN [S2-S4] .
Under the regulation of G proteins, p230 recycles between the cytosol and TGN membranes. The predicted p230 protein is highly hydrophilic, which is consistent with it being a peripheral membrane protein, and it contains a very high frequency of heptad repeats (85% of the polypeptide), characteristic of α helices that form dimeric coiled coil structures [S3] . A number of other Golgi autoantigens have been described which are also peripheral membrane proteins with extensive coiled-coil regions [S5,S6] ; these include golgin-245, which is related to p230 [S7] .
The localisation of p230 specifically to TGN membranes indicates the presence of a specific targeting sequence. We have recently shown that the non-coiled-coil carboxyterminal domain of p230 is necessary and sufficient for Golgi targeting [S8] . Here, we report a family of hydrophilic proteins from lower and higher eucaryotes that contain extensive coiled-coil domains and have a similar Golgi localisation sequence to p230.
Supplementary materials and methods
Cell culture and transfection
Cell lines were maintained in exponential growth as described [S2] . COS cells were transiently transfected using FuGene 6 transfection reagent (Boehringer Mannheim), according to the manufacturer's instructions. Immunofluorescence analyses of transfected cells were performed 48 h after transfection.
Antibodies
Affinity-purified human autoantibodies to p230 were obtained from a column of recombinant glutathione-S-transferase-p230 fusion protein and recognised epitopes between residues 1260-1490 of p230 [S2] . Rabbit polyclonal antibodies to β-COP were generated to the EAGE peptide [S9] . The monoclonal antibody (100.3) specific for γ-adaptin was obtained from Sigma. Conjugates were obtained from either Silenus Laboratories or Dako Corporation.
GFP constructs
The carboxy-terminal, non-coiled-coil, GLDs are as follows: p230, 98 amino acids; golgin-97, 87 amino acids; GCC1p, 70 amino acids; and Imh1p, 86 amino acids. All sequences were amplified by PCR. For the p230 GLD domain, pSVT7-p230 was used as template [S3,S8] ; for golgin-97 and GCC1p, HeLa cDNA, generated from total RNA, was used as template; and for Imh1p, S. cerevisiae genomic DNA was used as template. Products were confirmed by sequencing. Each domain was fused to the carboxyl terminus of GFP by cloning the PCR products into either the EcoRI site or the EcoRI/BamHI sites of the green fluorescent protein (GFP) vector, pEGFP-C1 (Clontech). Mutagenesis of the chimeric GFP constructs was carried out using inverse PCR mutagenesis [S10] . All constructs were verified by sequencing.
Immunofluorescence
Cells were fixed in 4% paraformaldehyde for 15 min, after which time free aldehyde groups were quenched in 50 mM NH 4 Cl/PBS, and the cells permeabilised with 0.1% Triton X-100 in PBS for 4 min. Alternatively, cells were fixed in methanol at -20°C for 5 min. Cell monolayers were incubated with PBS containing 5% fetal calf serum (PBS/FCS) for 20 min to reduce non-specific binding. Monolayers were then incubated with antibodies as described [S4,S8] , mounted in mowiol, and examined by confocal microscopy using a Bio-Rad MRC-1024 imaging system.
Immunoblotting
Immmunoblotting of transfected COS cells was carried out as previously described [S4] using anti-GFP antibodies (BoehringerMannheim) at 0.4 µg/ml.
